Compare MasterCard Inc (MA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Tenet Healthcare Corporation — how do they compare? MasterCard Inc trades at $562.59 (market cap $493.34B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: MasterCard Inc is far larger — about 23.6× Tenet Healthcare Corporation's market cap, and MasterCard Inc pays a 0.62% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| MA | THC | |
|---|---|---|
Market Cap | $493.34B | $20.93B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $598.96 | $262.63 |
52-Week Low | $471.55 | $161.37 |
Enterprise Value | $506.38B | $32.01B |
Dividend Yield | 0.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $561.44, down 0.27% on the day, with a bullish technical signal supported by moving averages and key support at $560. The company demonstrates robust fundamentals, with revenue growing to $32.79B in 2025 and a net income margin of 46.34%. Recent earnings beats and a strong analyst consensus highlight positive momentum amid expansion in digital payments and AI initiatives.
The outlook for MA remains favorable due to consistent earnings growth, high profitability, and strategic positioning in payment technology. Risks include competitive disruption from stablecoins and regulatory challenges. With a consensus price target of $660.85 and no sell ratings, Wall Street sentiment is strongly bullish, though investors should monitor execution on innovation and macroeconomic pressures.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
